Glycomira, LLC

Salt Lake City, UT 84108

SBIR Award Summary

Total Number of Awards 12
Total Value of Awards $3.54MM
First Award Date 04/24/09
Most Recent Award Date 09/01/17

Key Personnel

Last Name Name Awards Contact
Kennedy Thomas Preston Kennedy 5
Prestwich Glenn Downes Prestwich 9
Savage Justin Rodney Savage 6
Welm Alana L Welm 1
Gu Ying Gu 1
Rao Narayanam Venkateswara Rao 3
Ryan Maria E Ryan 4
Oottamasathien Siam Oottamasathien 1
Ambati Balamurali K Ambati 1
Zhang Jianxing Zhang 1
Lee Won Yong Lee 6
ALT JEREMIAH ANDREW ALT 1
PULSIPHER ABIGAIL PULSIPHER 1

12 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/01/17 - 08/31/18

ABSTRACT Oral mucositis is a devastatingly painful inflammatory disease that frequently develops during cancer therapy and affects half a million people in the US. The accompanying pain is so severe that patients often require narcotic pain medicines. The clinical manifestations are ulcers in the mouth and gastrointestinal tract, which are exac...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/01/16 - 08/31/17

ABSTRACT Oral mucositis is a devastatingly painful inflammatory disease that frequently develops during cancer therapy and affects half a million people in the US. The accompanying pain is so severe that patients often require narcotic pain medicines. The clinical manifestations are ulcers in the mouth and gastrointestinal tract, which are exac...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 08/01/16 - 07/31/17

PROJECT SUMMARYThis proposal aims to develop a therapeutic capable of preventing and treating the severe sinus inflammationassociated with chronic rhinosinusitis (CRS). CRS is a debilitating inflammatory disease of the sinuses thatimpacts over 40 million Americans and substantially diminishes the quality of life and productivity of affectedpatie...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 05/01/15 - 06/30/15

DESCRIPTION (provided by applicant): Chronic gingival inflammation of the soft tissue surrounding the tooth afflicts over half of all American adults. In the most severely affected, progression of this inflammatory process to the deeper periodontal ligaments and alveolar bone results in tooth loss from loss of mandibular anchorage. Gingivitis a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 07/01/14 - 06/30/15

DESCRIPTION (provided by applicant): Chronic gingival inflammation of the soft tissue surrounding the tooth afflicts over half of all American adults. In the most severely affected, progression of this inflammatory process to the deeper periodontal ligaments and alveolar bone results in tooth loss from loss of mandibular anchorage. Gingivitis a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 06/15/14 - 01/14/15

DESCRIPTION (provided by applicant): GlycoMira Therapeutics has developed safe and effective anti-inflammatory glycosaminoglycan derivatives and proposes to test the feasibility of using its lead compound to treat or prevent oral mucositis. Mucositis is a common and debilitating complication of cancer treatment. Cancer patients undergoing radia...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/20/13 - 08/31/14

DESCRIPTION (provided by applicant): Chronic gingival inflammation of the soft tissue surrounding the tooth afflicts over half of all American adults. In the most severely affected, progression of this inflammatory process to the deeper periodontal ligaments and alveolar bone results in tooth loss from loss of mandibular anchorage. Gingivitis a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/23/11 - 08/31/13

DESCRIPTION (provided by applicant): Heparin and its derivatives block P- and L-selectin mediated metastatic spread of cancer in animal models, and they potently inhibit the matrix degrading enzyme heparanase. Moreover, several large clinical trials performed with heparin or low molecular weight heparin have shown that survival is significantly ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/15/11 - 08/30/13

DESCRIPTION (provided by applicant): Painful bladder syndrome/interstitial cystitis (PBS/IC) is an indolent bladder disorder that has continued to be a debilitating disease with few truly effective treatment options. Inflammatory conditions that afflict the urinary bladder can lead to pelvic pain, debilitating urinary symptoms, bladder fibrosis,...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 08/01/11 - 07/31/12
PI: Ying Gu

DESCRIPTION (provided by applicant): Chronic gingival inflammation afflicts over half of all American adults and can progress to periodontal disease, eventually resulting in tooth loss. Periodontitis is initiated by bacterial infection of the gingival tissues through a subgingival microbial biofilm on the tooth surface that releases bacterial li...

Load More